Several of the largest banks—including Wells Fargo WFC, JPMorgan JPM, and Citigroup C —are set to report their first-quarter ...

Dow Jones Top Energy Headlines at 12 AM ET: The 'Real' Oil Price Is a Lot Higher Than It Looks | Oil ... Spot crude prices ...

"In a drawn--out [U.S.-Iran] conflict with sticky rather than spiking oil, FX should rotate back to terms-of-trade divergence ...

Dow Jones Top Markets Headlines at 11 PM ET: Oil Climbs, Asian Equities Fall as Peace Talks Collapse | U.S. ... Oil rose back above $100 a barrel and Asian equities fell, as the collapse of the ...

A Mango Pineapple Refresher and Red Bull Dragonberry Energizer are joining the new beverage lineup in U.S. restaurants. AI companies are rationing their offerings and products, rankling users-a ...

TOKYO--The failure of peace talks between the U.S. and Iran has raised fears of an energy supply shock and accelerating inflation, driving Japan's benchmark government bond yield to a nearly 30-year ...

Oil rose back above $100 a barrel and Asian equities fell, as the collapse of the U.S.-Iran peace talks poured cold water on ...

Dow Jones Top Markets Headlines at 9 PM ET: U.S. Threat to Blockade Hormuz Sets Up Risky New Showdown | The ... The move sets off a high-stakes war of attrition that will test who has the higher ...

Stock-market futures were down Sunday evening, suggesting investors were bracing for a sharp drop in major indexes after weekend talks between the U.S. and Iran failed to open the Strait of Hormuz and ...

If you have a wish list of stocks or closed-end funds that you have wanted to buy if they go on sale, now is the time to get it ready. That's especially true for anything that is volatile and thinly ...

Victory Giant Technology, a producer of high-precision printed circuit boards used by the likes of Nvidia, is seeking to raise over US$2 billion in a Hong Kong offering. The company, which is already ...

Dow Jones Top Company Headlines at 9 PM ET: Big Pharma Is Turning to China for the Newest Drug Ideas | How ... China's biotechs are faster and have lower costs, and its drug research threatens to soon ...